Sign in
CMT-3, a Chemically Modified Tetracycline, Inhibits Bony Metastases and Delays the Development of Paraplegia in a Rat Model of Prostate Cancer
Journal article

CMT-3, a Chemically Modified Tetracycline, Inhibits Bony Metastases and Delays the Development of Paraplegia in a Rat Model of Prostate Cancer

MARIE G SELZER, BAOQIAN ZHU, NORMAN L BLOCK and BAL L LOKESHWAR
Annals of the New York Academy of Sciences, Vol.878(1 INHIBITION OF), pp.678-682
1999-06
PMID: 10415806

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.132 Extracellular Matrix & Cell Differentiation
1.132.759 Matrix Metalloproteinases
Web Of Science research areas
Biochemistry & Molecular Biology
Medicine, Research & Experimental
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details